Healthcare Technology Report May 15, 2024
GenScript Biotech Corporation and Multiply Labs have announced a strategic partnership aimed at revolutionizing the cell therapy manufacturing process. By leveraging Multiply Labs’ expertise in robotics and GenScript’s leading cell isolation solution, the collaboration introduces a fully automated approach to cell therapy production, specifically targeting the labor-intensive cell isolation phase. This innovative automation technology promises to enhance efficiency, reduce human error, and significantly increase the scalability of cell therapies.
The partnership combines GenScript’s position as a global leader in life science research tools and services with...
Today's Sponsors
Today's Sponsor